NCT04528264

Brief Summary

Zygomatic arch fractures have always been treated with blind closed reduction and is the most commonly used method. Blind reduction of fractures might lead to inadequate reduction and associated complications of facial asymmetry and limitations in mouth opening which may require reoperation for correction. Various methods like portable CT scan, C arm fluoroscopy, endoscopy and ultrasound have been proposed and used to visualize the reduction for better outcome. Out of these, ultrasound is inexpensive, easily available, easy to use, non-ionizing and has greatest potential to be used as standard for visual reduction of zygomatic arch fractures. There are studies where ultrasound has been compared to blind method and other modalities but level I evidence and recommended protocol for its intraoperative use has been lacking.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 27, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

October 14, 2020

Status Verified

October 1, 2020

Enrollment Period

4 months

First QC Date

August 22, 2020

Last Update Submit

October 13, 2020

Conditions

Keywords

zygomatic arch fractureIntraoperative Imagingguided reduction

Outcome Measures

Primary Outcomes (4)

  • Post operative radiographic evidence of adequate reduction

    The radiographic evaluation will be performed blinded by one of the clinician oral and maxillofacial surgeons who will not be involved in any of the operations. The adequacy of reduction will be evaluated in a DICOM viewing software on axial scans to assess contour of the arch and step if any at the fracture site. 1. Good reduction : Absence of any step and straight contour of zygomatic arch symmetric to contralateral uninjured arch 2. Average reduction: Absence of any step but poor contour of zygomatic arch and asymmetric to contralateral uninjured arch 3. Poor reduction: Presence of both a cortical step and asymmetric arch compared to contralateral uninjured arch

    24 hours

  • Facial profile symmetry

    Clinical assessment will be performed blinded by a clinician oral and maxillofacial surgeon who will not be involved in any of the operations on first postoperative day, first follow up visit after one week of operation and 4 weeks of operation. Facial symmetry and projection will be assessed clinically by the clinician and graded as good, adequate and poor. A patient oriented clinical outcome is considered good practice and clinically relevant in modern evidence based medicine so patient response will be recorded as binary (yes/no) response regarding their view on facial symmetry.

    one week to four weeks

  • Number of reoperations

    Revision surgery required after failed reduction assessed and confirmed radiographically on CT scan and clinical assessment as well as patient reported measure of facial symmetry and adequate mouth opening.

    24 hours

  • Mouth opening

    Interincisal opening measured between the incisal tips of central incisor teeth and recorded in millimeter using a vernier caliper.

    at 24 hours postoperatively

Secondary Outcomes (3)

  • Operative time

    Intraoperative

  • Number of attempts or reduction

    Intraoperative

  • Cost of intervention

    Intraoperative

Study Arms (2)

Ultrasound guided

EXPERIMENTAL

Intraoperative high frequency ultrasound used to guide the reduction of depressed zygomatic arch.

Device: Intraoperative ultrasound guided

Conventional blind reduction technique

OTHER

Conventional blind reduction of zygomatic arch fracture will be conducted without any intraoperative imaging.

Other: Conventional blind reduction technique

Interventions

Samsung Mysono U6 machine with LN 15 linear (https://www.samsunghealthcare.com/en/products/UltrasoundSystem/MySono%20U6/General%20Imaging/transducers) probe capable of Musculoskeletal imaging will be used for visualization and location of fracture after which elevation and reduction of fracture will be attempted. The ultrasound probe will be used as described by McCann. Radiographic continuity of periosteal shadow without any step will be taken as end point for reduction and the procedure will be terminated.

Also known as: Intraoperative USG Imaging
Ultrasound guided

Conventional blind reduction technique

Also known as: comparator
Conventional blind reduction technique

Eligibility Criteria

Age6 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • years and above
  • fractured and depressed zygomatic arch requiring surgical reduction

You may not qualify if:

  • pregnant patients
  • not willing for participation
  • below 6 years age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

Study Officials

  • Ashutosh K Singh, MDS

    College of Medical Sciences, Nepal

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ashutosh K Singh, MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Sealed Envelope will be used to conceal allocation. Patients will be unaware of their group allocation. Outcome assessor will be blinded to the group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized double blind
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 22, 2020

First Posted

August 27, 2020

Study Start

June 1, 2021

Primary Completion

October 1, 2021

Study Completion

August 1, 2022

Last Updated

October 14, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share

Fully sharable link will be provided after study completion with deidentified data

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
6 months after completion and publication
Access Criteria
Decided by PI
More information